AVDL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $29,000.00

Insider Selling (Last 12 Months): $1,089,750.00

Avadel Pharmaceuticals Insider Trading History Chart

Avadel Pharmaceuticals Share Price & Price History

^$13.12

▲ +0.16 (1.23%)

As of 10/11/2024 01:00 AM ET

Days: 30 | 90 | 365

What Is the $7,882 Stimulus Payment 2024?

From Angel Publishing | Ad

Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here.

Avadel Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Thomas S Mchugh	CFO	Buy	2,000	$14.50	$29,000.00	80,500
12/28/2023	Mark Anthony Mccamish	Director	Sell	75,000	$14.53	$1,089,750.00	67,025
8/14/2023	Thomas S Mchugh	CFO	Buy	2,000	$14.45	$28,900.00	78,500
8/10/2023	Geoffrey Michael Glass	Director	Buy	14,000	$13.40	$187,600.00	59,000
8/10/2023	Gregory J Divis	CEO	Buy	10,000	$13.20	$132,000.00	159,100
5/9/2023	Linda Palczuk	Director	Buy	2,500	$14.76	$36,900.00	52,400
12/23/2022	Linda Palczuk	Director	Buy	2,000	$7.20	$14,400.00	49,900
11/29/2022	Thomas S Mchugh	CFO	Buy	5,000	$7.80	$39,000.00	76,500
5/31/2022	Eric J Ende	Director	Buy	15,000	$2.16	$32,400.00	114,900
5/27/2022	Linda Palczuk	Director	Buy	10,000	$1.60	$16,000.00	47,900
5/27/2022	Thomas S Mchugh	CFO	Buy	50,000	$2.14	$107,000.00	71,500

What Is the $7,882 Stimulus Payment 2024?

From Angel Publishing | Ad

Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here.

SEC Filings (Institutional Ownership Changes) for Avadel Pharmaceuticals (NASDAQ:AVDL)

69.19% of Avadel Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Avadel Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/11/2024	Creative Planning	12,381	$0.16M	0.0%	+8.2%	0.013%
10/11/2024	Compagnie Lombard Odier SCmA	5,000	$66K	0.0%	-33.3%	0.005%
10/3/2024	SG Americas Securities LLC	12,486	$0.16M	0.0%	N/A	0.013%
8/22/2024	Cetera Investment Advisers	107,787	$1.52M	0.0%	-5.4%	0.112%
8/20/2024	Nantahala Capital Management LLC	350,000	$4.92M	0.3%	N/A	0.364%
8/19/2024	Brandes Investment Partners LP	1,483,439	$20.89M	0.3%	+1.5%	1.543%
8/16/2024	Quarry LP	4,500	$63K	0.0%	N/A	0.005%
8/16/2024	Driehaus Capital Management LLC	470,341	$6.61M	0.1%	-1.1%	0.489%
8/15/2024	Dorsey Wright & Associates	125,905	$1.77M	0.5%	-1.4%	0.131%
8/15/2024	The Manufacturers Life Insurance Company	41,979	$0.59M	0.0%	N/A	0.044%
8/15/2024	Troluce Capital Advisors LLC	150,000	$2.11M	0.2%	N/A	0.156%
8/14/2024	Ally Bridge Group NY LLC	430,245	$6.05M	3.6%	-21.3%	0.448%
8/12/2024	Amalgamated Bank	3,198	$45K	0.0%	N/A	0.003%
8/9/2024	Renaissance Technologies LLC	64,396	$0.91M	0.0%	-84.1%	0.067%
8/8/2024	Beverly Hills Private Wealth LLC	10,379	$0.15M	0.0%	N/A	0.011%
8/8/2024	AdvisorShares Investments LLC	31,021	$0.44M	0.1%	-2.3%	0.032%
8/2/2024	Wealth Effects LLC	2,267,855	$31.89M	11.6%	+0.2%	2.359%
8/1/2024	Rhumbline Advisers	122,675	$1.73M	0.0%	+7,840.1%	0.128%
8/1/2024	Obermeyer Wood Investment Counsel Lllp	204,105	$2.87M	0.2%	-27.0%	0.212%
7/31/2024	Commonwealth Equity Services LLC	44,767	$0.63M	0.0%	+13.9%	0.047%
7/29/2024	Modera Wealth Management LLC	602,608	$8.47M	0.1%	+0.4%	0.627%
7/29/2024	Investors Asset Management of Georgia Inc. GA ADV	89,475	$1.26M	0.6%	+2.4%	0.093%
7/29/2024	Principal Financial Group Inc.	12,485	$0.18M	0.0%	N/A	0.013%
7/26/2024	Iridian Asset Management LLC CT	117,700	$1.66M	0.4%	+63.4%	0.122%
7/26/2024	Bank of New York Mellon Corp	325,388	$4.58M	0.0%	N/A	0.339%
7/22/2024	Krilogy Financial LLC	17,262	$0.24M	0.0%	N/A	0.018%
7/12/2024	Diversify Advisory Services LLC	13,096	$0.18M	0.0%	-59.5%	0.014%
5/24/2024	Cetera Advisors LLC	92,017	$1.55M	0.0%	+8.9%	0.096%
5/24/2024	Cetera Investment Advisers	113,978	$1.93M	0.0%	N/A	0.119%
5/16/2024	Janus Henderson Group PLC	12,915,160	$218.18M	0.1%	+16.1%	14.258%
5/16/2024	Kennedy Capital Management LLC	653,147	$11.03M	0.2%	+1.1%	0.721%
5/15/2024	Gendell Jeffrey L	5,708,118	$96.41M	3.7%	+1.7%	6.302%
5/14/2024	StemPoint Capital LP	223,660	$3.78M	1.0%	N/A	0.247%
5/9/2024	Lord Abbett & CO. LLC	193,233	$3.26M	0.0%	N/A	0.213%
5/8/2024	Avantax Advisory Services Inc.	55,756	$0.94M	0.0%	+123.9%	0.062%
5/8/2024	Russell Investments Group Ltd.	115,041	$1.94M	0.0%	N/A	0.127%
5/7/2024	Chilton Capital Management LLC	3,000	$51K	0.0%	N/A	0.003%
5/7/2024	Oppenheimer & Co. Inc.	37,095	$0.63M	0.0%	-2.2%	0.041%
5/7/2024	Obermeyer Wood Investment Counsel Lllp	279,494	$4.72M	0.3%	N/A	0.309%
5/6/2024	Quantbot Technologies LP	20,915	$0.35M	0.0%	N/A	0.023%
5/3/2024	GSA Capital Partners LLP	47,596	$0.80M	0.1%	N/A	0.053%
5/2/2024	Schulhoff & Co. Inc.	137,000	$2.31M	1.0%	+42.7%	0.151%
5/2/2024	Iridian Asset Management LLC CT	72,025	$1.22M	0.2%	+34.7%	0.080%
5/1/2024	BNP Paribas Financial Markets	4,469	$75K	0.0%	+60.5%	0.005%
5/1/2024	Diversify Advisory Services LLC	32,363	$0.54M	0.0%	N/A	0.036%
4/30/2024	Commonwealth Equity Services LLC	39,307	$0.66M	0.0%	-51.0%	0.043%
4/23/2024	Wealth Effects LLC	2,264,226	$38.24M	14.1%	-6.3%	2.500%
4/22/2024	Vivo Capital LLC	3,972,099	$67.09M	5.3%	-3.0%	4.385%
4/22/2024	Investors Asset Management of Georgia Inc. GA ADV	87,375	$1.48M	0.7%	-17.9%	0.096%
4/18/2024	Claro Advisors LLC	10,165	$0.17M	0.0%	N/A	0.011%
2/20/2024	Quarry LP	8,500	$0.12M	0.0%	N/A	0.009%
2/14/2024	RTW Investments LP	6,947,918	$98.11M	1.5%	-2.6%	7.736%
2/13/2024	Tower Research Capital LLC TRC	2,572	$36K	0.0%	-82.3%	0.003%
2/13/2024	CIBC Private Wealth Group LLC	63,629	$0.90M	0.0%	-31.9%	0.071%
2/9/2024	Brandes Investment Partners LP	1,533,614	$21.66M	0.3%	+5.9%	1.708%
2/7/2024	Avantax Advisory Services Inc.	24,900	$0.35M	0.0%	+3.8%	0.028%
2/7/2024	Jump Financial LLC	19,912	$0.28M	0.0%	-62.8%	0.022%
1/31/2024	Investors Asset Management of Georgia Inc. GA ADV	106,475	$1.50M	0.8%	N/A	0.119%
1/29/2024	Wealth Effects LLC	2,416,326	$34.12M	12.8%	+0.3%	2.690%
1/26/2024	Iridian Asset Management LLC CT	53,451	$0.76M	0.1%	+17.3%	0.060%
1/24/2024	China Universal Asset Management Co. Ltd.	10,327	$0.15M	0.0%	+349.4%	0.011%
1/10/2024	Blue Zone Wealth Advisors LLC	17,000	$0.24M	0.1%	-45.2%	0.019%
11/22/2023	Polar Capital Holdings Plc	4,512,964	$46.48M	0.3%	-0.5%	5.025%
11/15/2023	RTW Investments LP	7,136,415	$73.51M	1.6%	+4.8%	7.985%
11/15/2023	Kennedy Capital Management LLC	715,424	$7.37M	0.2%	+60.2%	0.801%
11/15/2023	Adage Capital Partners GP L.L.C.	1,725,000	$17.77M	0.0%	-35.6%	1.930%
11/14/2023	MPM Bioimpact LLC	664,224	$6.84M	1.8%	+72.5%	0.743%
11/13/2023	Gendell Jeffrey L	5,615,350	$57.84M	3.3%	+4.1%	6.283%
11/13/2023	Brandes Investment Partners LP	1,448,772	$14.92M	0.3%	+12.4%	1.621%
11/13/2023	Kestra Advisory Services LLC	21,950	$0.23M	0.0%	+7.3%	0.025%
11/9/2023	Cowen AND Company LLC	2,338,302	$24.09M	1.7%	-12.2%	2.616%
11/9/2023	Deutsche Bank AG	440,000	$4.53M	0.0%	+95.6%	0.492%
11/8/2023	Vivo Capital LLC	4,096,428	$42.19M	5.2%	+7.0%	4.584%
11/8/2023	Exencial Wealth Advisors LLC	12,000	$0.12M	0.0%	N/A	0.013%
11/8/2023	Oppenheimer & Co. Inc.	39,911	$0.41M	0.0%	+16.5%	0.045%
11/7/2023	Quantbot Technologies LP	7,587	$78K	0.0%	N/A	0.008%
11/7/2023	Jump Financial LLC	53,571	$0.55M	0.0%	N/A	0.060%
10/23/2023	Commonwealth Equity Services LLC	79,213	$0.82M	0.0%	+3.3%	0.089%
10/16/2023	Wealth Effects LLC	2,409,289	$24.82M	12.3%	+1.7%	2.696%
9/21/2023	Barclays PLC	49,335	$0.81M	0.0%	N/A	0.055%
8/14/2023	Samsara BioCapital LLC	967,527	$15.95M	2.8%	-31.4%	1.260%
8/14/2023	State of Wyoming	34,959	$0.58M	0.2%	+29.9%	0.046%
8/14/2023	Caption Management LLC	67,193	$1.11M	0.0%	-41.8%	0.088%
8/14/2023	UniSuper Management Pty Ltd	820,604	$13.52M	0.1%	N/A	1.069%
8/14/2023	Portolan Capital Management LLC	289,906	$4.78M	0.4%	+0.5%	0.378%
8/14/2023	Polar Capital Holdings Plc	4,534,921	$74.74M	0.5%	-0.8%	5.907%
8/11/2023	Pinebridge Investments L.P.	2,478	$41K	0.0%	-39.9%	0.003%
8/11/2023	Gendell Jeffrey L	5,396,060	$88.93M	6.9%	+1.8%	7.029%
8/11/2023	Velan Capital Investment Management LP	100,000	$1.65M	1.5%	+288.5%	0.130%
8/9/2023	Iridian Asset Management LLC CT	45,586	$0.75M	0.1%	N/A	0.059%
8/7/2023	Cowen AND Company LLC	2,664,076	$43.90M	3.6%	-28.6%	3.470%
8/4/2023	Investors Asset Management of Georgia Inc. GA ADV	93,975	$1.55M	0.8%	-28.2%	0.122%
8/3/2023	Barclays PLC	49,335	$0.81M	0.0%	N/A	0.064%
8/3/2023	Oppenheimer & Co. Inc.	34,248	$0.56M	0.0%	+46.6%	0.045%
8/2/2023	MAI Capital Management	51,270	$0.85M	0.0%	N/A	0.067%
7/28/2023	First Republic Investment Management Inc.	500,000	$8.24M	0.0%	N/A	0.651%
7/24/2023	Blue Zone Wealth Advisors LLC	15,000	$0.25M	0.1%	N/A	0.020%
7/18/2023	Wealth Effects LLC	2,369,089	$39.04M	17.2%	-5.2%	3.086%
7/14/2023	Edge Wealth Management LLC	150,000	$2.47M	0.5%	-11.8%	0.195%
7/13/2023	QP Wealth Management LLC	13,380	$0.22M	0.4%	N/A	0.017%

Data available starting January 2016

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Today's Range

Now: $13.12

$12.77

$13.16

50 Day Range

MA: $14.46

$12.44

$16.63

52 Week Range

Now: $13.12

$9.50

$19.09

Volume

642,533 shs

Average Volume

1,165,903 shs

Market Capitalization

$1.26 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of Avadel Pharmaceuticals?: Avadel Pharmaceuticals' top insider investors include:
Gregory J Divis (CEO)
Thomas S Mchugh (CFO)
Mark Anthony Mccamish (Director)
Geoffrey Michael Glass (Director)
Linda Palczuk (Director)
Learn More about top insider investors at Avadel Pharmaceuticals.
Who are the major institutional investors of Avadel Pharmaceuticals?: Avadel Pharmaceuticals' top institutional investors include:
SG Americas Securities LLC — 0.01%
Creative Planning — 0.01%
Compagnie Lombard Odier SCmA — 0.01%
Learn More about top institutional investors of Avadel Pharmaceuticals stock.
Which major investors are selling Avadel Pharmaceuticals stock?: Within the last quarter, AVDL stock was sold by these institutional investors:
Compagnie Lombard Odier SCmA
Which major investors are buying Avadel Pharmaceuticals stock?: During the last quarter, AVDL stock was acquired by institutional investors including:
SG Americas Securities LLC
Creative Planning
Within the last year, these company insiders have bought Avadel Pharmaceuticals stock:
Gregory J Divis (CEO)
Thomas S Mchugh (CFO)
Mark Anthony Mccamish (Director)
Geoffrey Michael Glass (Director)
Learn More investors buying Avadel Pharmaceuticals stock.